Metabolic Syndrome
Related entities
Findings (50)
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
mixedLate preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but
Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86
None
declineWomen with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven
Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80
None
declineWomen with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven
Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80
None
declineWomen with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven
Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80
None
declineWomen with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven
Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80
None
declineWomen with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven
Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80
None
declineWomen with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven
Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80
None
declineWomen with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven
Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80
None
declineWomen with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven
Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80
None
declineWomen with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven
Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80
None
declineWomen with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven
Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80
None
declineWomen with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven
Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80
None
declineWomen with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven
Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80
None
declineWomen with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven
Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80
None
declineWomen with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven
Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80
None
declineWomen with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven
Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80
None
declineWomen with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven
Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80
None
declineWomen with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven
Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80
None
declineWomen with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven
Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80
None
declineWomen with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven
Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80
None
declineWomen with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven
Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80
None
declineWomen with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven
Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80
None
declineWomen with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven
Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80
None
declineWomen with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven
Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80